BALMLAWRIEDiversified

Balmer Lawrie & Company Limited

Diversified · ISIN INE164A01016 · BSE 523319 · NSE EQ · FV ₹10
Last price
₹162
+0.23%today
What this company does

Balmer Lawrie & Company Limited operates in the Diversified sector. It booked ₹749 cr of revenue in its latest quarter (Q1 FY27) and kept 9.5% of sales as profit. It is the 4th largest of 5 Diversified companies we track, by market value.

In the report:
64out of 100
Equitytale Health Score
Mixed

Healthier than 64% of listed companies we score, on all six measures of filed financials. Each measure is ranked against the 611–2,858 companies that reported it.

Measures financial condition, not whether to buy. Learn what this score means · How this is calculated

Price momentum
oversold
RSI (14)
26

At close. Not part of the score.

Profitability & returns56

How much profit it earns on the money it employs

Balance sheet70

How much it owes, and whether earnings cover the interest

Cash quality67

Whether reported profit actually arrives as cash

Growth & consistency61

Whether sales and profit have grown, and how steadily

Valuation46

What today's price implies, against our models or its peers

Governance & risk100

How much of the promoters' stake is pledged, and how much they hold · highest in its sector on what we could measure

Is this company doing well?
not investment advice
Strengths
Makes a profit
Sales up 10% vs last year
No promoter shares pledged
Virtually debt-free
Watch-outs
! Operating cash flow is negative

What if I invest in BALMLAWRIE?

Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.

You would put in
₹12.00 lakh
120 instalments
At 2% a year, it would become
₹13.28 lakh

The slider starts at 2%, taken from this company's own free-cash-flow trend. That is history, not a forecast — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.

Key ratios · latest quarter + price
₹162 +0.23%
latest close · 2026-09-17
1-year return
+29.1%
52-wk low ₹10352-wk high ₹182
Is it cheap or expensive?
What you pay for the profits, book value and cash flow. Higher isn't automatically worse — it can signal faster growth.
P/E ratio9.7Low
LowAverageHigh
P/B ratio1.34Moderate
Below bookModerateHigh
EV / EBITDA6.4Low
LowAverageHigh
How good is the business?
How much profit it earns from its money and its sales.
Return on equity13.8%Fair
WeakFairStrong ▸15%
Return on capital14.2%Fair
WeakFairStrong
Net margin9.5%Decent
ThinDecentStrong
EBITDA margin14.8%Decent
ThinDecentHealthy
Is it financially safe?
How much it owes, and whether it can comfortably cover it.
Debt to equity0.04Comfortable
LowModerateHigh ▸1
Interest cover7.1×Strong
RiskyOkayStrong ▸5×
Current ratio2.13Ample
Tight ◂1HealthyAmple
More figures
Market cap
₹2,778 cr
Book value
₹121
EPS
₹4.18
latest quarter
Net debt
₹41 cr
owes more than its cash
Enterprise value
₹2,819 cr
EBITDA
₹442 cr
annualised
EBIT
₹363 cr
annualised
Operating margin
12.1%
Return on assets
8.5%
Earnings yield
10.29%
P/S
0.93
Sales / share
₹175.1
Tax rate
27.5%
Face value
₹10
Shares
17.1 cr
Working capital
₹894 cr
Current assets
₹1,683 cr
Current liabilities
₹789 cr
Delivery %
54.6%
Strong / safeFairWeak / riskyValuation — a level, not good/badBands are general rules of thumb, not advice.

P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-09-17.

Worth vs price · from the FY 2025 report & filings
not investment advice
Looks overpricedMedium confidence
Median of 2 models ₹102 vs market price ₹162 — price is 59% above it
Safety cushion-58.8%(target ≥ +20%)
Models span ₹87₹118, midpoint ₹102
Model ₹102
Price ₹162
Cheap sideExpensive side

An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.

P&L · Q1 FY27 (consolidated)
Revenue from Operations₹749 cr
Other Income₹11 cr
Total Income₹759 cr
Cost of Materials₹495 cr
Purchases of Stock-in-Trade₹4 cr
Inventory Change (±)₹-16 cr
Employee Benefit Expense₹70 cr
Finance Costs₹13 cr
Depreciation & Amortisation₹20 cr
Other Expenses₹95 cr
Total Expenses₹681 cr
Profit before Tax₹78 cr
Tax Expense₹21 cr
Share of JV / Associates₹14 cr
Net Profit₹71 cr
Net margin on total income9.3%
Where the money goes · Q1 FY27
% of total income
Materials + stock-in-trade₹484 cr62.6%
Employee benefit expense₹70 cr9.0%
Finance costs₹13 cr1.7%
Depreciation & amortisation₹20 cr2.5%
Other expenses₹95 cr12.3%
Tax expense₹21 cr2.8%
Profit for the period₹71 cr9.2%
Total income ₹759 cradds up to ₹100 ✓
Quarterly results · consolidated (₹ cr)
MetricQ3 FY26Q4 FY26Q1 FY27
Revenue657 cr744 cr749 cr
Total income664 cr763 cr759 cr
Expenses598 cr668 cr681 cr
Profit before tax65 cr95 cr78 cr
Tax18 cr30 cr21 cr
Net profit (owners' share)67 cr85 cr71 cr
Net margin (owners' share, on revenue)10.1%11.4%9.5%
EPS (₹)3.894.954.18
YoY (latest quarter): total income +10.0% · net profit +3.6%
Balance sheet & cash flow · as of Mar 2026
Debt-free
Total assets
₹3,349 cr
Shareholder equity
₹2,069 cr
parent shareholders
Total debt
₹75 cr
Cash
₹34 cr
Cash flow · H1 FY26
Operating
₹-68 cr
Investing
₹164 cr
Financing
₹-97 cr
Peer comparison
Diversified · by market value
CompanyPriceMarket capP/E
Godrej Industries Limited₹1,127₹37,967 cr33.4
3M India Limited₹32,530₹36,645 cr58.3
DCM Shriram Limited₹984₹15,424 cr5.5
Balmer Lawrie & Company Limitedthis company₹162₹2,778 cr9.7
TTK Healthcare Limited₹1,049₹1,482 cr17.4
Same industry · latest reported numbers · not a recommendation.
Corporate actions
Dividend yield
5.23%
trailing 12 months
Dividend / share (TTM)
₹8.5
Last dividend
₹4.25
ex 11 Sep 2026
ActionDetailEx-date
Dividend₹4.25 / share11 Sep 2026
Dividend₹4.25 / share11 Mar 2026
Dividend₹8.5 / share16 Sep 2025
Dividend₹8.5 / share19 Sep 2024
Dividend₹7.5 / share20 Sep 2023
Dividend₹6.5 / share19 Sep 2022
Who owns it · 2026-06-30
No pledge
Promoter
FII / Foreign
2.4%
DII / Domestic
1.8%
Retail / others
95.8%
Smart-money activity
Bulk / block deals
short · NSE9027 Jan 26
short · NSE2524 Oct 25
short · NSE3083 Oct 25
What shareholders were asked to approve

A company cannot decide everything on its own. Things like a top executive’s pay, issuing new shares, or re-appointing a director have to be put to the people who own the company, and they vote — one vote per share. So whoever owns the most shares has the most say.

Yearly shareholder meeting · 23 Sep 2025
See the official result
1
To consider and adopt the Audited Financial Statements of the Company (both Standalone and Consolidated) for the Financial Year ended on 31st March, 2025 together with the Reports of the Board of Directors and Auditors thereon and other Statements attached thereto along with the Comments of Comptroller and Auditor General of India thereon
Backed by 100% of shareholders other than promotersneeded 50%
10.84 cr votes for, 766 against · 0% of mutual funds and other big investors said no
2
To declare dividend for the Financial Year ended on 31st March, 2025
Backed by 100% of shareholders other than promotersneeded 50%
10.85 cr votes for, 676 against · 0% of mutual funds and other big investors said no
3
To appoint a Director in place of Shri Saurav Dutta (DIN: 10042140), a Director who retires by rotation and being eligible, offers himself for re-appointment
Backed by 98% of shareholders other than promotersneeded 50%
10.65 cr votes for, 20.22 L against · 83% of mutual funds and other big investors said no
4
To fix the remuneration of the Statutory Auditors of the Company (including Branch Auditors) for the Financial Year 2025-26
Backed by 100% of shareholders other than promotersneeded 50%
10.85 cr votes for, 776 against · 0% of mutual funds and other big investors said no

Every vote count above is taken from the result the company filed with the stock exchange, certified by an independent counter. To work out what would have happened without the promoters, we simply remove their votes and re-apply the same legal bar the proposal had to clear. Nothing here is an estimate or an opinion.

How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.